GHK-Cu for GLP-1 hair loss: separating signal from TikTok hype

What did @elizabethsglp1journey actually say?

The creator confirmed GHK-Cu "can" help with hair loss, called it "a copper peptide" and compared it to "a collagen peptide," then shared injection site experience, saying her stomach worked better than her thigh and that the thigh "burned" on a second attempt. That is the entirety of the factual content here. There are no dosing claims, no disease cure claims, and no wild mechanistic leaps. The video is short, personal, and mostly anecdotal, which matters when evaluating what it actually says versus what viewers might infer from it.

The reply context (responding to @staceysview) suggests someone asked whether GHK-Cu could address the hair thinning that some GLP-1 users experience, likely from telogen effluvium triggered by rapid weight loss. That framing is reasonable and the creator's confirmation, while not evidence-based, isn't baseless either.

Does the science back this up?

Partially, but the evidence base is thinner than the peptide community tends to admit. GHK-Cu (glycine-histidine-lysine copper complex) does have real biological activity on hair follicles, but most of that data comes from in vitro studies or small trials, not the kind of robust clinical evidence that would satisfy a dermatologist.

Uno (1987, Journal of Investigative Dermatology) showed GHK-Cu stimulated hair follicle size in scalp tissue models. Pickart and Margolina (2018, Biomolecules) reviewed GHK-Cu's role in tissue repair and noted it upregulates several growth factors, including vascular endothelial growth factor, which matters for follicle vascularity. A 2019 study by Jeong et al. (International Journal of Molecular Sciences) found copper peptides promoted hair follicle cycling in mouse models. Human randomized controlled trial data on injected GHK-Cu for hair loss specifically? It essentially does not exist at the level needed to make strong claims. Topical formulations have more published data than injectable ones in this context.

The comparison to "a collagen peptide" is where things get scientifically loose. GHK-Cu is a tripeptide with a copper ion chelated to it. Its mechanism involves copper-dependent enzymes, collagen synthesis stimulation, and antioxidant activity. Collagen peptides are hydrolyzed collagen fragments that work primarily through amino acid provision. Calling them alike oversimplifies meaningfully different biochemistry.

What did they get wrong (or right)?

The creator got the category right: GHK-Cu is a legitimate copper peptide with documented biological activity relevant to hair follicles. Credit where it is due. The injection site observation, stomach over thigh, is a reasonable personal data point. Subcutaneous abdominal tissue tends to be less sensitive and easier to access consistently, so that tracks.

What is wrong, or at least imprecise, is the "like a collagen peptide" comparison. It will mislead viewers into thinking these are interchangeable or mechanistically similar. They are not. GHK-Cu's copper chelation is central to how it functions. Collagen peptides do not carry a metal ion. This is not a minor distinction if someone is trying to understand what they are injecting and why.

The bigger issue the video sidesteps entirely: GHK-Cu is not FDA-approved for hair loss. Injectable GHK-Cu exists in a regulatory gray zone, typically compounded, and the evidence supporting injection over topical application for this specific use case has not been established in clinical trials. Viewers may walk away thinking this is an established protocol. It is not.

What should you actually know?

GHK-Cu has genuine science behind it, but that science does not yet support confident claims about injected use for GLP-1-related hair loss specifically. Telogen effluvium from rapid weight loss typically resolves on its own within six to nine months once nutritional status stabilizes. Before adding an unregulated injectable peptide, that context matters.

If you are experiencing hair loss on a GLP-1 medication, the more established interventions include adequate protein intake (research consistently points to protein deficit as a driver), iron and ferritin optimization, and consultation with a dermatologist who can assess whether telogen effluvium, androgenetic alopecia, or something else is at play. Topical minoxidil has actual RCT evidence for hair retention. Injected GHK-Cu does not, at least not for this population.

For anyone considering peptide therapy through a regulated telehealth platform, the standard of care involves a provider reviewing your labs, health history, and current medications before any injectable protocol. Anecdotal TikTok reports are a starting point for questions, not a prescription.